Copyright Reports & Markets. All rights reserved.

Global Remicade (infliximab) Drug Market Insights and Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Remicade (infliximab) Drug Product Introduction
  • 1.2 Key Market Segments in This Study
  • 1.3 Key Manufacturers Covered: Ranking of Global Top Remicade (infliximab) Drug Manufacturers by Revenue in 2019
  • 1.4 Market by Type
    • 1.4.1 Global Remicade (infliximab) Drug Market Size Growth Rate by Type
    • 1.4.2 Brands Drugs
    • 1.4.3 Generic Drugs
  • 1.5 Market by Application
    • 1.5.1 Global Remicade (infliximab) Drug Market Size Growth Rate by Application
    • 1.5.2 Crohn's Disease
    • 1.5.3 Pediatric Crohn's Disease
    • 1.5.4 Ulcerative Colitis
    • 1.5.5 Pediatric Ulcerative Colitis
    • 1.5.6 Other
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Remicade (infliximab) Drug Market Size, Estimates and Forecasts
    • 2.1.1 Global Remicade (infliximab) Drug Revenue Estimates and Forecasts 2015-2026
    • 2.1.2 Global Remicade (infliximab) Drug Production Capacity Estimates and Forecasts 2015-2026
    • 2.1.3 Global Remicade (infliximab) Drug Production Estimates and Forecasts 2015-2026
  • 2.2 Global Remicade (infliximab) Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.3 Analysis of Competitive Landscape
    • 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 2.3.2 Global Remicade (infliximab) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 2.3.3 Global Remicade (infliximab) Drug Manufacturers Geographical Distribution
  • 2.4 Key Trends for Remicade (infliximab) Drug Markets & Products
  • 2.5 Primary Interviews with Key Remicade (infliximab) Drug Players (Opinion Leaders)

3 Market Size by Manufacturers

  • 3.1 Global Top Remicade (infliximab) Drug Manufacturers by Production Capacity
    • 3.1.1 Global Top Remicade (infliximab) Drug Manufacturers by Production Capacity (2015-2020)
    • 3.1.2 Global Top Remicade (infliximab) Drug Manufacturers by Production (2015-2020)
    • 3.1.3 Global Top Remicade (infliximab) Drug Manufacturers Market Share by Production
  • 3.2 Global Top Remicade (infliximab) Drug Manufacturers by Revenue
    • 3.2.1 Global Top Remicade (infliximab) Drug Manufacturers by Revenue (2015-2020)
    • 3.2.2 Global Top Remicade (infliximab) Drug Manufacturers Market Share by Revenue (2015-2020)
    • 3.2.3 Global Top 10 and Top 5 Companies by Remicade (infliximab) Drug Revenue in 2019
  • 3.3 Global Remicade (infliximab) Drug Price by Manufacturers
  • 3.4 Mergers & Acquisitions, Expansion Plans

4 Remicade (infliximab) Drug Production by Regions

  • 4.1 Global Remicade (infliximab) Drug Historic Market Facts & Figures by Regions
    • 4.1.1 Global Top Remicade (infliximab) Drug Regions by Production (2015-2020)
    • 4.1.2 Global Top Remicade (infliximab) Drug Regions by Revenue (2015-2020)
  • 4.2 North America
    • 4.2.1 North America Remicade (infliximab) Drug Production (2015-2020)
    • 4.2.2 North America Remicade (infliximab) Drug Revenue (2015-2020)
    • 4.2.3 Key Players in North America
    • 4.2.4 North America Remicade (infliximab) Drug Import & Export (2015-2020)
  • 4.3 Europe
    • 4.3.1 Europe Remicade (infliximab) Drug Production (2015-2020)
    • 4.3.2 Europe Remicade (infliximab) Drug Revenue (2015-2020)
    • 4.3.3 Key Players in Europe
    • 4.3.4 Europe Remicade (infliximab) Drug Import & Export (2015-2020)
  • 4.4 China
    • 4.4.1 China Remicade (infliximab) Drug Production (2015-2020)
    • 4.4.2 China Remicade (infliximab) Drug Revenue (2015-2020)
    • 4.4.3 Key Players in China
    • 4.4.4 China Remicade (infliximab) Drug Import & Export (2015-2020)
  • 4.5 Japan
    • 4.5.1 Japan Remicade (infliximab) Drug Production (2015-2020)
    • 4.5.2 Japan Remicade (infliximab) Drug Revenue (2015-2020)
    • 4.5.3 Key Players in Japan
    • 4.5.4 Japan Remicade (infliximab) Drug Import & Export (2015-2020)

5 Remicade (infliximab) Drug Consumption by Region

  • 5.1 Global Top Remicade (infliximab) Drug Regions by Consumption
    • 5.1.1 Global Top Remicade (infliximab) Drug Regions by Consumption (2015-2020)
    • 5.1.2 Global Top Remicade (infliximab) Drug Regions Market Share by Consumption (2015-2020)
  • 5.2 North America
    • 5.2.1 North America Remicade (infliximab) Drug Consumption by Application
    • 5.2.2 North America Remicade (infliximab) Drug Consumption by Countries
    • 5.2.3 U.S.
    • 5.2.4 Canada
  • 5.3 Europe
    • 5.3.1 Europe Remicade (infliximab) Drug Consumption by Application
    • 5.3.2 Europe Remicade (infliximab) Drug Consumption by Countries
    • 5.3.3 Germany
    • 5.3.4 France
    • 5.3.5 U.K.
    • 5.3.6 Italy
    • 5.3.7 Russia
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Remicade (infliximab) Drug Consumption by Application
    • 5.4.2 Asia Pacific Remicade (infliximab) Drug Consumption by Regions
    • 5.4.3 China
    • 5.4.4 Japan
    • 5.4.5 South Korea
    • 5.4.6 India
    • 5.4.7 Australia
    • 5.4.8 Taiwan
    • 5.4.9 Indonesia
    • 5.4.10 Thailand
    • 5.4.11 Malaysia
    • 5.4.12 Philippines
    • 5.4.13 Vietnam
  • 5.5 Central & South America
    • 5.5.1 Central & South America Remicade (infliximab) Drug Consumption by Application
    • 5.5.2 Central & South America Remicade (infliximab) Drug Consumption by Country
    • 5.5.3 Mexico
    • 5.5.3 Brazil
    • 5.5.3 Argentina
  • 5.6 Middle East and Africa
    • 5.6.1 Middle East and Africa Remicade (infliximab) Drug Consumption by Application
    • 5.6.2 Middle East and Africa Remicade (infliximab) Drug Consumption by Countries
    • 5.6.3 Turkey
    • 5.6.4 Saudi Arabia
    • 5.6.5 U.A.E

6 Market Size by Type (2015-2026)

  • 6.1 Global Remicade (infliximab) Drug Market Size by Type (2015-2020)
    • 6.1.1 Global Remicade (infliximab) Drug Production by Type (2015-2020)
    • 6.1.2 Global Remicade (infliximab) Drug Revenue by Type (2015-2020)
    • 6.1.3 Remicade (infliximab) Drug Price by Type (2015-2020)
  • 6.2 Global Remicade (infliximab) Drug Market Forecast by Type (2021-2026)
    • 6.2.1 Global Remicade (infliximab) Drug Production Forecast by Type (2021-2026)
    • 6.2.2 Global Remicade (infliximab) Drug Revenue Forecast by Type (2021-2026)
    • 6.2.3 Global Remicade (infliximab) Drug Price Forecast by Type (2021-2026)
  • 6.3 Global Remicade (infliximab) Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

7 Market Size by Application (2015-2026)

  • 7.2.1 Global Remicade (infliximab) Drug Consumption Historic Breakdown by Application (2015-2020)
  • 7.2.2 Global Remicade (infliximab) Drug Consumption Forecast by Application (2021-2026)

8 Corporate Profiles

  • 8.1 Janssen
    • 8.1.1 Janssen Corporation Information
    • 8.1.2 Janssen Overview
    • 8.1.3 Janssen Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.1.4 Janssen Product Description
    • 8.1.5 Janssen Related Developments
  • 8.2 Hospira
    • 8.2.1 Hospira Corporation Information
    • 8.2.2 Hospira Overview
    • 8.2.3 Hospira Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.2.4 Hospira Product Description
    • 8.2.5 Hospira Related Developments
  • 8.3 Celltrion Healthcare
    • 8.3.1 Celltrion Healthcare Corporation Information
    • 8.3.2 Celltrion Healthcare Overview
    • 8.3.3 Celltrion Healthcare Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.3.4 Celltrion Healthcare Product Description
    • 8.3.5 Celltrion Healthcare Related Developments
  • 8.4 Epirus Biopharmaceuticals
    • 8.4.1 Epirus Biopharmaceuticals Corporation Information
    • 8.4.2 Epirus Biopharmaceuticals Overview
    • 8.4.3 Epirus Biopharmaceuticals Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.4.4 Epirus Biopharmaceuticals Product Description
    • 8.4.5 Epirus Biopharmaceuticals Related Developments
  • 8.5 Samsung Bioepsis
    • 8.5.1 Samsung Bioepsis Corporation Information
    • 8.5.2 Samsung Bioepsis Overview
    • 8.5.3 Samsung Bioepsis Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.5.4 Samsung Bioepsis Product Description
    • 8.5.5 Samsung Bioepsis Related Developments

9 Remicade (infliximab) Drug Production Forecast by Regions

  • 9.1 Global Top Remicade (infliximab) Drug Regions Forecast by Revenue (2021-2026)
  • 9.2 Global Top Remicade (infliximab) Drug Regions Forecast by Production (2021-2026)
  • 9.3 Key Remicade (infliximab) Drug Production Regions Forecast
    • 9.3.1 North America
    • 9.3.2 Europe
    • 9.3.3 China
    • 9.3.4 Japan

10 Remicade (infliximab) Drug Consumption Forecast by Region

  • 10.1 Global Remicade (infliximab) Drug Consumption Forecast by Region (2021-2026)
  • 10.2 North America Remicade (infliximab) Drug Consumption Forecast by Region (2021-2026)
  • 10.3 Europe Remicade (infliximab) Drug Consumption Forecast by Region (2021-2026)
  • 10.4 Asia Pacific Remicade (infliximab) Drug Consumption Forecast by Region (2021-2026)
  • 10.5 Latin America Remicade (infliximab) Drug Consumption Forecast by Region (2021-2026)
  • 10.6 Middle East and Africa Remicade (infliximab) Drug Consumption Forecast by Region (2021-2026)

11 Value Chain and Sales Channels Analysis

  • 11.1 Value Chain Analysis
  • 11.2 Sales Channels Analysis
    • 11.2.1 Remicade (infliximab) Drug Sales Channels
    • 11.2.2 Remicade (infliximab) Drug Distributors
  • 11.3 Remicade (infliximab) Drug Customers

12 Market Opportunities & Challenges, Risks and Influences Factors Analysis

  • 12.1 Remicade (infliximab) Drug Industry
  • 12.2 Market Trends
  • 12.3 Market Opportunities and Drivers
  • 12.4 Market Challenges
  • 12.5 Remicade (infliximab) Drug Market Risks/Restraints
  • 12.6 Porter's Five Forces Analysis

13 Key Finding in The Global Remicade (infliximab) Drug Study

    14 Appendix

    • 14.1 Research Methodology
      • 14.1.1 Methodology/Research Approach
      • 14.1.2 Data Source
    • 14.2 Author Details

    Remicade (infliximab) Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Remicade (infliximab) Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Remicade (infliximab) Drug market is segmented into
    Brands Drugs
    Generic Drugs

    Segment by Application, the Remicade (infliximab) Drug market is segmented into
    Crohn's Disease
    Pediatric Crohn's Disease
    Ulcerative Colitis
    Pediatric Ulcerative Colitis
    Other

    Regional and Country-level Analysis
    The Remicade (infliximab) Drug market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Remicade (infliximab) Drug market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
    Competitive Landscape and Remicade (infliximab) Drug Market Share Analysis

    Remicade (infliximab) Drug market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Remicade (infliximab) Drug by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Remicade (infliximab) Drug business, the date to enter into the Remicade (infliximab) Drug market, Remicade (infliximab) Drug product introduction, recent developments, etc.
    The major vendors covered:
    Janssen
    Hospira
    Celltrion Healthcare
    Epirus Biopharmaceuticals
    Samsung Bioepsis
    ...

    Buy now